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Abstract
ATP6AP2, an essential accessory component of the vacuolar H+ ATPase (V-ATPase), has been associated with intellectual
disability (ID) and Parkinsonism. ATP6AP2 has been implicated in several signalling pathways; however, little is known
regarding its role in the nervous system. To decipher its function in behaviour and cognition, we generated and characterized
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conditional knockdowns ofATP6AP2 in the nervous system ofDrosophila andmousemodels. InDrosophila,ATP6AP2 knockdown
induced defective phototaxis and vacuolated photoreceptor neurons and pigment cells when depleted in eyes and altered
short- and long-termmemory when depleted in themushroom body. In mouse, conditional Atp6ap2 deletion in glutamatergic
neurons (Atp6ap2Camk2aCre/0 mice) caused increased spontaneous locomotor activity and altered fear memory. Both Drosophila
ATP6AP2 knockdown and Atp6ap2Camk2aCre/0 mice presented with presynaptic transmission defects, and with an abnormal
number and morphology of synapses. In addition, Atp6ap2Camk2aCre/0 mice showed autophagy defects that led to axonal and
neuronal degeneration in the cortex and hippocampus. Surprisingly, axon myelination was affected in our mutant mice, and
axonal transport alterationswere observed inDrosophila. In accordancewith the identiﬁed phenotypes across species, genome-
wide transcriptome proﬁling of Atp6ap2Camk2aCre/0 mouse hippocampi revealed dysregulation of genes involved in myelination,
action potential, membrane-bound vesicles and motor behaviour. In summary, ATP6AP2 disruption in mouse and ﬂy leads to
cognitive impairment andneurodegeneration,mimicking aspects of the neuropathologyassociatedwithATP6AP2mutations in
humans. Our results identify ATP6AP2 as an essential gene for the nervous system.
Introduction
ATP6AP2 has been associated with cognitive disorders based on
a mutation identiﬁed in one family with seven affected males
presenting with mild-to-moderate intellectual disabilities,
delayed motor milestones and speech acquisition, and general-
ised tonic-clonic seizures (1,2). However, the implication of
ATP6AP2 in intellectual disabilities has been questioned after
an ATP6AP2 mutation was identiﬁed in a single male within a
cohort of 6500 sequenced control exomes (3). More recently,
another family with Parkinsonian features and variably pene-
trant spasticity was reported to have an ATP6AP2 mutation
(4,5). The mutations identiﬁed in these two families are different
splicing mutations that give rise to skipping of exon 4 of the
ATP6AP2 gene in both cases.
ATP6AP2 was described as a receptor for renin and prorenin
((P)RR). The binding of renin or (P)RR to the ATP6AP2 extracellular
domain activates the renin–angiotensin system, leading to the
production of angiotensin II and also to activation of other path-
ways, such as themitogen-activated protein kinase (MAPK) path-
way (6). However, ATP6AP2 is also found in invertebrates such as
Drosophila and Caenorhabditis elegans, which do not possess the
renin–angiotensin system (7), suggesting alternative functions
for ATP6AP2. Indeed, this protein was also isolated as an acces-
sory component of the vacuolar H+ ATPase (V-ATPase) (6,8).
V-ATPase is a multisubunit proton pump that consists of a V0
proton-translocation domain, a V1 pump domain and two as-
sociated proteins, Ac45 and ATP6AP2. This pump is responsible
for the acidiﬁcation of intracellular and some extracellular com-
partments and thus is crucial for many fundamental processes
that require an intactmembrane-trafﬁcking system (9), including
endocytosis, protein and signalling molecule processing, protein
sorting and trafﬁcking, and lysosomal and autophagosomal
enzyme activation (10).
In agreement with its fundamental role, several studies re-
garding ATP6AP2 in mouse, zebraﬁsh, frog and Drosophila have
shown that its full deletion is lethal (reviewed in 11). Moreover,
the tissue-speciﬁc deletion of Atp6ap2 in mouse cardiomyocytes
and podocytes also leads to lethality, as both conditional knock-
out mice died between 2 and 3 weeks after birth (12–14). Con-
comitantly, multivesicular bodies and autophagic vacuoles
accumulated in the tissues with deleted Atp6ap2 owing to autop-
hagic ﬂux alterations (12,14). Recent work in the Drosophila wing
disc epithelium has demonstrated that ATP6AP2 (VhaM8.9/
VhaPRR) is required for V-ATPase function in vesicular acidiﬁca-
tion, endosomal sorting andprotein degradation (15). In addition,
ATP6AP2was shown to be essential for both of theWnt/β-catenin
andWnt/planar cell polarity (PCP) signalling pathways inXenopus
and Drosophila (16–18). Whereas Cruciat and collaborators (17)
identiﬁed Xenopus ATP6AP2/(P)RR as an adaptor between
V-ATPase and the Wnt complex, Hermle and collaborators (18)
found that its function in proper trafﬁcking of the planar cell
polarity molecular core machinery in the Drosophila wing disc is
independent of V-ATPase.
Surprisingly little is known regarding the function of ATP6AP2
in the nervous system, the tissue typemost prominently affected
in humans with ATP6AP2mutations. In zebraﬁsh, the absence of
ATP6AP2/(P)RR induces necrosis in the central nervous system,
eventually resulting in embryonic lethality (19). In Xenopus,
ATP6AP2/(P)RR is required for mediating Wnt signalling during
early CNS development, including neural patterning (17,20). In
mouse, Atp6ap2 regulates adult hippocampal neurogenesis via
Wnt/β-catenin and Wnt/PCP signalling pathways (21). Whether
ATP6AP2 executes speciﬁc roles in postmitotic neurons that can
directly underlie impaired cognitive and motor functions in in-
dividuals with ATP6AP2mutations is unclear; however, this ques-
tion is important in the light of the unclear causative role of this
gene in intellectual disabilities (ID) and Parkinsonismwith spasti-
city. To decipher the function ofATP6AP2 in behaviour and cogni-
tion, we generated and characterized conditional ATP6AP2
knockouts in Drosophila and mouse nervous system models.
Results
Drosophila ATP6AP2 knockdown in the eye causes
defective phototaxis and ultrastructural defects, and
knockdown in the mushroom body causes defects in
short- and long-term memory
First, we investigated the Drosophila orthologue of the ID can-
didate gene ATP6AP2, also termed VhaM8.9/VhaPRR and from
here on referred to as ATP6AP2, in a combination of Drosophila
phototactic behaviourandmorphological studies on theﬂyeye as
primary readouts (22). We used the UAS-Gal4 system and two
independent conditional RNAi constructs, UAS-ATP6AP2RNAi1
and UAS-ATP6AP2RNAi2, to induce ATP6AP2 knockdown in the de-
veloping eye with the GMR-Gal4; UAS-Dicer-2 driver. The potency
of both lines to induce knockdown was conﬁrmed by qPCR (see
Materials and Methods). Both lines were effective, with UAS-AT-
P6AP2RNAi1 inducing slightly stronger knockdown compared
with UAS-ATP6AP2RNAi2 (Supplementary Material, Fig. S2A).
ATP6AP2 eye-speciﬁc knockdown did not result in external eye
morphology phenotypes (data not shown) but dramatically af-
fected performance in the phototaxis assay.Whereas the genetic
background control animals were strongly attracted by light
[phototaxis index (PI) = 5.2], the majority of ATP6AP2 eye-speciﬁc
knockdown animals remained in the ﬁrst vial, resulting in PIs of
merely 2.3 for both RNAi conditions (Fig. 1A and data not shown).
Figure 1.Knockdown ofDrosophila ATP6AP2 disrupted phototaxis and short- and long-termmemory. (A) Distribution of adult ﬂies in the phototaxis assaymeasuring their
visually induced activity and resulting phototaxis indexes (PI). Control ﬂies (GMR-Gal4/+;UAS-Dicer-2/+) and ﬂies with either eye-speciﬁc knockdown of ATP6AP2 (UAS-
ATP6AP2RNAi1/GMR-Gal4;UAS-Dicer-2/+) or Vha100-1 (GMR-Gal4/+;UAS-Dicer-2/Vha100-1RNAi) are shown. ATP6AP2 and Vha100-1 knockdown animals showed dramatically
decreased PIs, revealing functional photoreceptor neuron defects. (B and C) Histological and high-magniﬁcation electron microscopy images of the same genotypes
presented in A. The pigment cells surrounding the photoreceptor neurons were strongly vacuolated (asterisk). Vesicular structures were present in the PR cytoplasm
(PRC) (arrowheads). Rhabdomeres (R), the apical photosensitive membrane domains of photoreceptors, were intact in ATP6AP2 and Vha100-1 knockdown eyes. (A–C)
Note the strikingly similar phenotypes caused by knockdown of ATP6AP2 and Vha100-1. (D) Short-term and (E) long-term memory in control (w+,UAS-Dicer-2/Y;247-
Gal4/+;+/+) and ATP6AP2 mushroom body-speciﬁc knockdown ﬂies (w+,UAS-Dicer-2/Y; 247-Gal4/UAS-ATP6AP2RNAi1; +/+) in the courtship conditioning paradigm. Left
panels show boxplots of the courtship indexes (CI) of naïve (N) and trained (T) males. Signiﬁcance of courtship suppression upon training was assessed with ANOVA
and post hoc Tukey’s multiple comparison test. Panels on the right side represent the learning indexes, which were calculated from CIs as speciﬁed in the Material and
Methods section. The loss of ATP6AP2 caused a statistically signiﬁcant reduction in courtship-based short-term memory (STM, A) and long-term memory (LTM, B)
compared with controls. Statistical test: bootstrap analysis with 10 000 replicates. *P < 0.05, **P < 0.01, ***P < 0.001.
This ﬁnding suggested potential dysfunction of ATP6AP2-
deﬁcient photoreceptor (PR) neurons. To obtain further insights
into the cellular basis of these defects, we analysed the structural
integrity of PRs by histological semi- and ultrathin sectioning.
While ATP6AP2-deﬁcient ommatidia and PRs showed overall
intact organization, PR-surrounding pigment cells were highly
vacuolated (Fig. 1B, asterisk). Electronmicroscopy of PRs revealed
a large number of accumulated vesicular structures in PR cyto-
plasm (Fig. 1C, arrowheads). Interestingly, identical phenotypes,
low PI, vacuolated pigment cells and large vesicular structures in
PRs were observed upon knockdown of the Drosophila V-ATPase
subunit Vha100-1 (Fig. 1A–C, Supplementary Material, Fig. S2A, 22),
whose homologue, ATP6V0A2, is also implicated in ID (23).
To address the role of ATP6AP2 in the development and func-
tion of the nervous system, we knocked down ATP6AP2 in post-
mitotic neurons. The induction of UAS-ATP6AP2RNAi1 using the
elav-Gal4 promoter in the presence of UAS-Dicer-2 induced lethal-
ity at different developmental stages, primarily during larval de-
velopment. The few adult survivors that were obtained showed
strongly reduced spontaneous movements and poor climbing
abilities. The induction of the somewhat less potent UAS-
ATP6AP2RNAi2 line under the same conditions did not result in
lethality, but the progenies showed similar, albeit less affected,
locomotion defects, together indicating that ATP6AP2 is required
in neurons for survival and normal ﬂy behaviour.
Next, we asked whether ATP6AP2 is required for cognitive
processes in Drosophila. We chose the stronger RNAi line UAS-
ATP6AP2RNAi1 and the 247-Gal4 promoter to limitATP6AP2 knock-
down to the mushroom bodies (MBs), the major learning and
memory centre of the Drosophila brain. Interestingly, we noticed
that ATP6AP2 MB-speciﬁc knockdown ﬂies showed elevated ac-
tivity in response to stimulation such as banging or soft-tapping
against the vials, with repeated jumping, wing ﬂapping and
crashing. Then, we tested memory in the courtship conditioning
paradigm (24,25). In this paradigm, the courtship behaviour of
male ﬂies is conditioned by exposure to non-receptive females,
which suppresses courtship and thus decreases the courtship
index (CI, the percentage of time spent on courtship during a
10-min interval) in subsequent encounters when tested after
1 h (short-term memory, Fig. 1D) and 24 h (long-term memory,
Fig. 1E). Naïve ATP6AP2RNAi1 males (N) courted at similar level
as naïve controls (N). Nevertheless, when tested for short-term
memory, they partially suppressed courtship after training (T)
but failed to suppress courtship in the long-term memory re-
gime. Calculating the learning indexes for ATP6AP2RNAi1 ﬂies
against genetic background control ﬂies revealed signiﬁcant
defects in short- and long-term memory.
Mouse Atp6ap2 deletion in glutamatergic neurons
causes increased spontaneous locomotor activity
and altered contextual and cued fear memory
To address whether ATP6AP2 controls similar functions in
mammals, we investigated its role in mouse. First, we analysed
its expression pattern in adult mouse brain sections by immuno-
histochemistry. We showed that Atp6ap2 is expressed in most
tested brain areas with the highest expression observed in the
cortex, the hippocampus, the medial habenular nucleus, the
cerebellum, the medulla and the olfactory bulb (Fig. 2A and
data not shown). Then, to determine which cell types express
Atp6ap2, we performed colocalization studies. In the cortex and
the hippocampus, we did not detect Atp6ap2 expression in astro-
cytes (GFAP marker, data not shown); however, considering the
limited sensitivity of immunohistochemistry, we cannot exclude
that Atp6ap2 is expressed at low level. We observed Atp6ap2 ex-
pression in glutamatergic and GABAergic neurons as revealed by
its colocalization with Camk2a-positive cells (Fig. 2C and F) and
GAD67-positive cells (Fig. 2E and H), respectively. All Atp6ap2-
positive cells were either positive for Camk2a or GAD67, suggest-
ing that Atp6ap2 is expressed primarily in neurons in the cortex
and hippocampus.
Thus, we decided to inactivate Atp6ap2 gene function specif-
ically in glutamatergic neurons using a conditional approach by
crossing a ﬂoxed Atp6ap2 transgenic mouse line with a Cam-
k2aCre transgenic mouse line, which expressed the Cre recom-
binase in glutamatergic neurons (26). Atp6ap2 deletion was ﬁrst
analysed in Atp6ap2Camk2aCre/0 and Atp6ap2Camk2aCreERT2/0 brain
tissues (cortex, hippocampus, hypothalamus, striatum and
Figure 2. Atp6ap2 is expressed in both glutamatergic and GABAergic neurons in the adult mouse brain. (A) Immunohistochemical analysis of adult mouse brain sections
showed Atp6ap2 expression in most tested brain areas. Strong expression of Atp6ap2 was detected in the cortex, hippocampus, thalamus and hypothalamus of wt mice
(A), and net decreases in Atp6ap2 expression were observed in the cortex and hippocampus of Atp6ap2Camk2aCre/0(B). Scale bars: 500 µm. (C–H) High-magniﬁcation images
of the cortex and the CA1 area corresponding to the dashed boxes drawn in A and B. Atp6ap2 is expressed in glutamatergic neurons as revealed by its colocalization with
Camk2a (a marker of glutamatergic neurons)-positive cells in the cortex and in the CA1 area of wt mice (C and F, respectively). In Atp6ap2Camk2aCre/0 mice, almost no
Camk2a-positive cells from the cortex and CA1 expressed Atp6ap2 (D and G, respectively). Atp6ap2 is also expressed in GABAergic cells as revealed by Atp6ap2
colocalization with GAD67 (a marker of GABAergic neurons)-positive cells in the cortex and in the CA1 area (E and H, respectively). Scale bars: 100 µm.
cerebellum) by RT droplet digital PCR. We observed a strong de-
crease of Atp6ap2 expression in the cortex and the hippocampus,
and lower or no decrease in the other brain tissues (Supplemen-
tary Material, Fig. S2B). We noticed less Atp6ap2 deletion in all
brain tissues analysed in Atp6ap2Camk2aCreERT2/0 mice compared
with Atp6ap2Camk2aCre/0 mice (Supplementary Material, Fig. S2B).
Next, we conﬁrmedAtp6ap2 deletion by immunohistochemistry.
In the cortex and the hippocampus, we showed a net decrease in
the number of Atp6ap2-positive cells in Atp6ap2Camk2aCre/0 mice
when compared with wt mice (Fig. 2B and A, respectively). More-
over, colocalization analyses showed that Atp6ap2 was only
poorly detected in Camk2a-positive cells (Fig. 2D and G) but re-
mained present in GAD67-positive cells (data not shown). In
the other brain regions, we did not observe any changes in
Atp6ap2 expression, except a decreased expression in the gran-
ule cell layer of the olfactory bulb (data not shown). Finally, to de-
termine Atp6ap2 deletion efﬁciency in Camk2a-positive cells, we
quantify the number of Camk2a-positive cells that still expressed
Atp6ap2 in the cortex and the hippocampus of Atp6ap2Camk2aCre/0
mice by immunohistochemistry with anti-Camk2a and anti-
Atp6ap2 antibodies. We observed that 42.76 ± 1.55% of Camk2a-
positive cells still expressed Atp6ap2 in the cortex, and only
16.19 ± 3.93% of Camk2a-positive cells still expressed Atp6ap2
in the hippocampus, conﬁrming a higher deletion efﬁciency in
the hippocampus than in the cortex.
Atp6ap2Camk2aCre/0 males physical appearance and body
weights were normal and did not show any obvious sign of al-
tered sensory or vestibular functions. To assessmouse locomotor
activity, Atp6ap2Camk2aCre/0 mice were submitted to several tests.
When circadian activity was examined, overall locomotor activ-
ity (Fig. 3A and C) signiﬁcantly increased in Atp6ap2Camk2aCre/0
males comparedwithwt counterparts (t22≥ 2.93, P < 0.01); the dif-
ference was speciﬁcally observed during the dark phases (F1,22≥
6.00, P < 0.05 for locomotion; F1,22≥ 4.21, P < 0.05 for rears; Fig. 3C).
Atp6ap2Camk2aCre/0males also showed signiﬁcantly increased local
activity in the front part of the cages throughout the light/dark
cycle (t22 = 2.65, P < 0.05; Fig. 3B), which might be interpreted as
stereotypic behaviour. When Atp6ap2 was deleted in adults
using tamoxifen injection, similar locomotor patterns were ob-
served (data not shown). In the open-ﬁeld arenas, on one hand,
Atp6ap2Camk2aCre/0 males showed a signiﬁcantly higher level of
locomotor activity and rears (t22≥ 4.09, P < 0.001; Fig. 3D). On the
other hand, the percentage of time spent in the centre of the
open-ﬁeld arena was comparable between genotypes (t22 = 1.02,
NS; Fig. 3D), suggesting normal anxiety-related behaviour in
Atp6ap2Camk2aCre/0 males. In the Y-maze, the number of visited
arms signiﬁcantly increased in mutants (t22 = 3.26, P < 0.01;
Fig. 3E), thus conﬁrming increased locomotor activity following
Atp6ap2 deletion in glutamatergic neurons.
Different assays were performed to test learning andmemory
abilities of Atp6ap2Camk2aCre/0 mutants. In the Y-maze, the per-
centage of spontaneous alternations was comparable between
genotypes (t22 = 0.22, NS; Fig. 3E), indicating thatworkingmemory
was not affected inAtp6ap2Camk2aCre/0mice. In the new object rec-
ognition test, Atp6ap2 mutants showed increased object explor-
ation durations compared with wt during the acquisition trial
(t22 = 3.30, P < 0.01; Fig. 4A), which could be due to their increased
locomotor activity.When the animals were allowed to discrimin-
ate between a novel and a familiar object 3 h after acquisition,
object recognition performance was comparable between geno-
types (t22 = 0.34, NS; Fig. 4A), suggesting that recognitionmemory
is not affected in Atp6ap2 mutants. In the water maze, both wt
and Atp6ap2Camk2aCre/0 mice were able to acquire spatial allo-
centric learning over the training sessions (Supplementary
Material, Fig. S3A and B). In contrast, Atp6ap2 mutants showed
reduced speed (F1,22 = 17.72, P < 0.001) and higher latencies
(F4,88 = 2.50, P < 0.05) to reach the platform position than wt
while having the same distance travelled (Supplementary
Material, Fig. S3A–C), suggesting altered swimming abilities.
When the platform was removed from the pool during the
probe trial 1 to 2 h after training, wt and Atp6ap2Camk2aCre/0 mice
showed a comparable number of platform crosses and a compar-
able preference for the target quadrant (Supplementary Material,
Fig. S3D and E). These data conﬁrm normal spatial learning in
Atp6ap2Camk2aCre/0 mice.
To determine Atp6ap2Camk2aCre/0 males’ social behaviour, the
animals were allowed to explore freely a congener and an object
placed simultaneously at two opposite goal boxes of a runway.
Wt and mutants explored the congener grid signiﬁcantly more
than the object grid (snifﬁng duration: wt males: t11 = 5.34,
P < 0.001; Atp6ap2Camk2aCre/0 males: t11 = 3.96, P < 0.01; paired
t-test), reﬂecting no difference in social recognition performance
between both genotypes (% snifﬁng duration: t ≥ 3.19, P < 0.01,
one group t-test; Fig. 4B).
Acoustic startle and prepulse inhibition (PPI) of the startle re-
ﬂex were also evaluated. Atp6ap2Camk2aCre/0 mice showed signiﬁ-
cantly lower startle reactivity for higher pre-pulses and lower
startle responses for high sudden acoustic stimulus (t22 ≥ 2.45,
P < 0.05; Fig. 4C). The level of PPI was comparable between geno-
types (F1,22 = 0.44, NS; Fig. 4D), suggesting normal sensorimotor
gating in mutants.
In the fear conditioning test, the baseline level of immobility
during the habituation to the conditioning cages and the sup-
pression of activity in response to footshocks during condition-
ing were lower in Atp6ap2Camk2aCre/0 compared with wt mice
(F1,22 = 4.32, P < 0.05; t22 = 3.72, P < 0.001). When the animals were
re-exposed to the same context 24 h after conditioning, both wt
and Atp6ap2Camk2aCre/0 mice showed signiﬁcant increases in
immobility compared with the baseline. However, contextual
freezing performance signiﬁcantly decreased in Atp6ap2 mu-
tants (F1,22 = 6.72, P < 0.05; Fig. 4E). When the animals were
placed in a new context, the presentation of conditioned stim-
uli (CS) alone induced clear fear reaction in both genotypes;
nevertheless, Atp6ap2Camk2aCre/0 mice showed lower cued
freezing performance than wt (F1,22 = 3.50, P < 0.01; Fig. 4E).
Interestingly, the adult deleted Atp6ap2Camk2aCreERT2/0 mice
also showed decreased contextual and cued freezing perfor-
mances (P < 0.05; Fig. 4F). Overall, Atp6ap2 deletion in glutama-
tergic neurons induced substantial deﬁcits in both cued and
contextual fear conditioning, suggesting altered emotional
learning and memory.
ATP6AP2 is required for presynaptic transmission
in Drosophila and mouse
We used electrophysiological approaches to further investigate
and determine the cause of behavioural and cognitive deﬁcits
in Drosophila and mouse models. First, we performed electroreti-
nograms (ERGs) (27) on Drosophila control and ATP6AP2 knock-
down eyes. ERGs are extracellular ﬁeld recordings that assess
the potential difference between the photoreceptor layer and
the remainder of the ﬂy body during light stimulation, revealing
photoreceptor transients (de- and repolarization) and synaptic
communication (‘on’ and ‘off’ transients). The presynaptic
knockdown of ATP6AP2 in photoreceptors using either UAS-AT-
P6AP2RNAi1 or UAS-ATP6AP2RNAi2 caused synaptic defects charac-
terized by a complete absence of ‘on’ and ‘off’ transients (Fig. 5A
and data not shown).
Figure 3.Atp6ap2Camk2aCre/0mouse line showed increased spontaneous activity in different behavioural experiments. (A–C) In the circadian activity test,Atp6ap2Camk2aCre/0
mice showed signiﬁcantly increased locomotor activity speciﬁcally during the dark phase (A and C) and increased local activity in the front part of the cages throughout
the light/dark cycle (B). (D) The distance travelled and the rear number in the open ﬁeld signiﬁcantly increased in Atp6ap2Camk2aCre/0 mice compared with wt. (E) In the
Y-maze, working memory was comparable between genotypes, as reﬂected by the percentage of spontaneous alternations (SPAs). The number of visited arms
signiﬁcantly increased in mutants. *P < 0.05, **P < 0.01, ***P < 0.001 versus wt.
Then, we analysed synaptic transmission in hippocampal
projections to the basolateral amygdala (Hip-BLA) in mice.
Indeed, Atp6ap2Camk2aCre/0 mice exhibit pronounced deﬁcits in
freezing behaviour when re-exposed to a context in which they
received electric footshock previously (Fig. 4E). Recently, we de-
monstrated that efﬁcacy at hippocampal projections to the baso-
lateral amygdala is of crucial importance for the aversive
conditioned response in mice (28). We deﬁned some experimen-
tal conditions that allow the functional isolation of Hip-BLA pro-
jections using opsin-based strategies combined with genetic
deletion ofAtp6ap2 in the presynaptic compartment. Speciﬁcally,
co-injections of AAV-Cre and AAV-ChR2-GFP viruses were per-
formed in the caudal hippocampus, and after a delay allowing
both opsin expression andAtp6ap2 removal, electrophysiological
recordings were performed in BLA principal neurons (Fig. 5B
and C). To verify that the AAV-Cre strategy efﬁciently depleted
endogenous Atp6ap2 proteins, we performed immunodetection
of Atp6ap2 at the infection site by visualizing GFP expression as-
sociatedwith AAV-ChR2 infection. As shown in Figure 5B, there is
a clear absence of Atp6ap2 labelling in the GFP-expressing area.
Next we compared synaptic transmission between groups of
mice in which AAV-ChR2-GFP was used solely (wt-pre) or to-
getherwith AAV-Cre (KO-pre) (Fig. 5D–F). First, to assess for global
changes in synaptic efﬁcacy, we applied single, short, 460-nm
light ﬂashes of increasing amplitude while recording BLA princi-
pal cells at−70mV in the voltage-clampmode, thereby building so-
called input/output (I/O) curves. We did not observe any difference
between the two recordinggroups (datanot shown), suggesting that
the presence of Atp6ap2 within the pre-synapse is not essential for
basal neurotransmission. Next, to investigate whether Atp6ap2
wouldaffect short-termplasticity,we tested responses topaired sti-
mulations applied at short (50 ms) time intervals (Fig. 5D). A very
pronouncedpairedpulse depression (PPD)wasobserved in the con-
trol group (wt-pre) (wt-pre: Peak 2: 0.11 ± 0.02% of Peak 1, n = 33,
Fig. 5D–F). Interestingly, the PPDwas less pronounced in KO-pre re-
cordings (KO-pre: Peak 2: 0.30 ± 0.05% of Peak 1, n= 38, P < 0.01 com-
paredwithwt-pre, Fig. 5D–F). These results suggested that Atp6ap2
could be essential for maintaining the release probability at excita-
tory synapses. Interestingly, when stimulations were applied at
lower frequencies, no difference was observed (data not shown).
Figure 4. The Atp6ap2Camk2aCre/0 mouse line showed altered contextual and cued fear memory and increased startle responses. (A) In the object recognition task, the
duration of object exploration during acquisition signiﬁcantly increased in Atp6ap2Camk2aCre/0 mice. Object recognition performance was not affected in mutants. (B) In
the social recognition test, both genotypes spent more time exploring the congener than an object and showed comparable preference indexes for the congener.
(C) Atp6ap2Camk2aCre/0 mutants showed signiﬁcantly lower startle reactivity for higher pre-pulses and lower startle responses for high sudden acoustic stimulus.
(D) The level of PPI was comparable between genotypes. (E) In the fear conditioning paradigm, when animals were re-exposed in the same context 24 h after
conditioning, contextual freezing performance signiﬁcantly decreased in Atp6ap2Camk2aCre/0 mutants. When the animals were placed in a new context,
Atp6ap2Camk2aCre/0 mice also showed lower cued freezing performance than wt. (F) Atp6ap2Camk2aCreERT2/0 mice also showed decreased contextual and cued freezing
performances (P < 0.05). *P < 0.05, **P < 0.01 versus wt; ##P < 0.01, ###P < 0.001 versus the object grid; §§P < 0.01, §§§P < 0.001 versus the chance level.
As one of the families with ATP6AP2mutation presented gen-
eralized tonic-clonic seizures, we evaluated Atp6ap2Camk2aCre/0
males for susceptibility to seizures either spontaneously using
electroencephalography (EEG) recording with cortical electrodes
or following injection of a pro-convulsive compound, the pentyle-
netetrazol (PTZ). After >24 h of EEG recording, we did not observe
any spontaneous seizures both in wt and Atp6ap2Camk2aCre/0 mice
(Supplementary Material, Fig. S4A). We also tested the PTZ, a
pro-epileptic drug, at twodifferent doses (30 and 40mg/kg; Supple-
mentary Material, Fig. S4B–G), and we did not ﬁnd increased sus-
ceptibility to seizures. On the contrary, the percentage of animals
with seizures was reduced and the latency of seizures was in-
creased in the Atp6ap2Camk2aCre/0 mice compared with wt mice
(Supplementary Material, Fig. S4B–G). Altogether, the data suggest
that thedeletionAtp6ap2 in glutamatergicneuronsmice isunlikely
to increase susceptibility to seizures.
Atp6ap2 localizes primarily in the endoplasmic
reticulum in the soma and in axons and the
presynaptic compartment
To better understand the function of Atp6ap2 in neurons, we
analysed its subcellular localization in cortical and hippocampal
Figure 5. ATP6AP2 deletion induced presynaptic transmission defects in ﬂy andmousemodels. (A) Electroretinograms (ERGs) from control ﬂies (GMR-Gal4/+; UAS-Dicer-2/+) in
black and from ﬂies with eye-speciﬁc knockdown of ATP6AP2 (ATP6AP2 RNAi1/GMR-Gal4; UAS-Dicer-2/+) in red. ATP6AP2 knockdown caused a complete absence of ‘on’
and ‘off’ transients and diminished amplitude photoreceptor de- and repolarization. (B) Speciﬁc presynaptic deletion of Atp6ap2was achieved by the simultaneous viral
infection of AAV-Cre and AAV-ChR2-GFP constructs within the caudal hippocampus. An in situ control of Atp6ap2 deletion in the GFP area was tested using
immunohistochemistry. Scale bar: 500 µm. (C) Excitatory synaptic transmission at hippocampal to BLA projections was examined using coronal amygdala-containing
acute slices. Synaptic transmission was evoked by short ﬂashes of 460-nm light delivered through an optical ﬁbre. (D) Postsynaptic responses to paired light
stimulations separated by 50 ms were used to test for release probability at hippocampal terminals. Recordings were performed in Atp6ap2 ﬂx mice infected solely
with AAV-ChR2 (ChR2) or AAV-ChR2 and AAV-Cre (ChR2/Cre). (D and E) In the absence of presynaptic Atp6ap2, we observed a change in the EPSC2/EPSC1 ratio (PPR
ratio). Statistics includes results from three experimental replicates. The number of recorded cells is indicated.
neurons from primary neuronal cultures. First, we performed co-
localization studies with markers of different cellular compart-
ments. We showed that Atp6ap2 is predominantly localised in
the endoplasmic reticulum (ER) where it colocalized with the
ER marker KDEL-ER (Supplementary Material, Fig. S5A) but not
in the Golgi because it did not colocalize with the Golgi marker
GM130 (data not shown).We performed additional colocalization
analyses withmarkers revealing the different vesicular compart-
ments: Rab5b and EEA1 for early endosomes, Rab7 for late endo-
somes, lamp1 for lysosomes and LC3B for autophagosomes.
Atp6ap2 partially colocalizedwith all the different vesicular com-
partments (Supplementary Material, Fig. S5B–E), including lyso-
somes (Supplementary Material, Fig. S5D) and autophagosomes
(Supplementary Material, Fig. S5E). Our results are in agreement
with the colocalization quantiﬁcation studies published by Ki-
nouchi and collaborators (29). Immunogold electron microscopy
showed high gold particle concentration in axons and, in particu-
lar, in myelinated axons where the gold particles were present in
both axons andmyelin sheaths (Supplementary Material, Fig. S5J
and K). In addition, colocalization studies with pre- and post-
synaptic markers revealed that Atp6ap2 colocalized with several
presynaptic markers, including synaptophysin (Supplementary
Material, Fig. S5G), VGLUT1 (Supplementary Material, Fig. S5H)
and VGLUT2 (Supplementary Material, Fig. S5I), and only poorly
colocalized with PSD95, a postsynaptic marker (Supplementary
Material, Fig. S5F). In conclusion, Atp6ap2 is present in dendrites
and axons, with predominance in axons.
Presynaptic knockdown of Drosophila ATP6AP2 disrupts
synapse morphology, ultrastructural organization and
axonal transport of the active zone component BRP
Based on ATP6AP2 electrophysiology in Drosophila and localiza-
tion in mouse, we examined the consequences of ATP6AP2 loss
on synapse development andmorphology. The Drosophila neuro-
muscular junction (NMJ), which is a well-established model sys-
tem for mammalian central excitatory/glutamatergic synapses,
has already provided major insights into synapse biology under-
lying ID (30). The NMJ synaptic terminal is organized into synaptic
boutons that resemble pearls on a string, each containing numer-
ous chemical synapses for vesicle release, so-called active zones
(Supplementary Material, Fig. S6). We knocked down ATP6AP2
presynaptically using the pan-neuronal elav-Gal4 driver and ex-
amined NMJ morphology. Computer-assisted quantiﬁcation of
immunolabelling with the postsynaptic marker DLG, highlight-
ing the overall morphology of the synaptic terminal, and with
the key presynaptic scaffold protein BRP (31), an integral compo-
nent of active zones, revealed undergrowth of the synaptic ter-
minal in both ATP6AP2RNAi1 and ATP6AP2RNAi2 conditions and a
reduced number of active zones in the stronger knockdown con-
dition (ATP6AP2RNAi1) (Fig. 6A and B). Furthermore, we noticed a
high number of so-called satellite boutons (32), small immature
extra-boutons splitting off from the primary synaptic terminal
(Fig. 6C). Because satellite boutons, to our surprise, seemed
more frequent in the otherwise weaker ATP6AP2RNAi2-induced
knockdown condition, we followed up with a second presynaptic
marker, synaptotagmin (anti-Syt), which highlights bouton or-
ganization (Fig. 6D). Anti-Syt staining revealed a striking increase
in satellite boutons also in the ATP6AP2RNAi1 knockdown synap-
ses. Frequently, satellites remain extremely small in this severe
condition (Fig. 6D, arrowheads). Bouton organization of the pri-
mary synaptic terminal was also affected consistently in both
ATP6AP2 knockdown conditions, with boutons not being proper-
ly separated and spaced but fused, with some fused to the degree
that individual boutons were no longer quantiﬁable (Fig. 6D).
Ultrastructural analysis ofATP6AP2 knockdown synapses revealed
the presence of large multivesicular body-like organelles (Fig. 6E,
asterisk). The ultrastructure of T-bars at active zones was also per-
turbed (Fig. 6F). We conclude that the loss of ATP6AP2 impairs the
growth of synaptic terminals, promotes satellite bouton formation
and affects bouton, subsynaptic and ultrastructural organization.
While inspectingNMJmorphology in pan-neuronally induced
ATP6AP2RNAi1 animals, which are characterized by a decreased
amount of BRP-positive active zones, we found that BRP strongly
accumulated in motor axons (Fig. 6G). In contrast, BRP, which is
required for the structural integrity and function of the synaptic
active zone (31,33), is transported to the presynaptic terminal
with high efﬁciency in wild-type animals, indicating that
ATP6AP2 is required for BRP axonal transport.
MouseAtp6ap2 deletion in glutamatergic neurons causes
an autophagy defect leading to axonal and neuronal
degeneration and to synapse splitting
To analyse the consequences of Atp6ap2 deletion in the mouse
brain, we performed electron microscopy morphological stud-
ies in the cortex and hippocampus, the two regions with the
highest amount of Atp6ap2 deletion in our mouse model.
Several alterations were observed in the Atp6ap2Camk2aCre/0 mice.
First, we revealed the presence of an important number of degen-
erating neurons in both the cortex and hippocampus of the
Atp6ap2Camk2aCre/0 mice but not in the wt mice (Fig. 7A–D); the
hippocampus seemed to be more affected than the cortex. The
process of neuronal death was not apoptosis, as determined by
the lack of cleaved caspase 3 signal in the cortex and the hippo-
campus of Atp6ap2Camk2aCre/0mice (data not shown). Rather, cells
die from necrosis as suggested in electron microscopy images
showing features of necrotic cells: absence of fragmented nuclei,
presence of empty cytoplasm and dilatation ofmitochondria and
of the rough ER (Fig. 7B and D). In addition, we showed that neur-
onal degeneration is accompanied by the degeneration of axons,
particularly myelinated axons (Fig. 7E–L). We also observed re-
ductions in myelin thickness in both degenerating and non-
degenerating axons (Fig. 7F, H, J and L). As shown in Figure 7F
and 7H, the reduced myelin thickness is due to a decreased
number ofmyelinwraps around axons. Some axons also had dis-
turbed microtubules (Fig. 7F). Finally, we observed the presence
of an increased number of vacuoles in the neurons of mutant
mice (Fig.7Q–T). Because several publications reported the in-
volvement of the autophagy pathway in the phenotype induced
byAtp6ap2 deletion in podocytes and cardiomyocytes (12–14) and
because we observed an increased number of vacuoles in neu-
rons in the Atp6ap2Camk2aCre/0 cortex and hippocampus, we tested
whether autophagy would be perturbed in our mouse model. We
used immunohistochemistry to examine the protein levels of p62
and UBQLN2, two autophagy substrates reﬂecting autophagy ac-
tivity, in brain sections from Atp6ap2Camk2aCre/0 and wt mice. We
observed increased p62 and UBQLN2 staining in the cortex and
hippocampus of mutant mice in comparison with the wt mice
(Fig. 8). The most affected area was the CA3 area of the hippocam-
pus, with massive increases in p62 and UBQLN2 staining, which
corresponded to an increased number of dying neurons in this re-
gion, as shown in Figure 8D and L. The dentate gyruswas also high-
ly affected, and the CA1 area and cortex seemed to be less affected
(Fig. 8). To test whether autophagy was also affected in Drosophila,
we stained adult brains of pan-neuronally induced ATP6AP2RNAi1
and ATP6AP2RNAi2 ﬂies and their appropriate background controls
for the p62 orthologue Ref(2)p. BothATP6AP2RNAi1 andATP6AP2RNAi2
conditions showed a highly signiﬁcantly increase in Ref(2)p levels
(Fig. 8Q–T and Supplementary Material, Fig. S7). Thus, loss of
ATP6AP2 in mouse and Drosophila impairs autophagy.
To determine whether synapses were also affected in mouse,
we analysed the morphology and size of synapses from the cor-
tex and hippocampus of Atp6ap2Camk2aCre/0 and control mice.
We assessed thewidth of the synapses [active zone/postsynaptic
density (PSD)] and the size (diameter) of the synaptic vesicles
on electron microscopy images. We found a signiﬁcant reduction
in the mean width of synapses in the cortex [mean width: 266.3
± 128.2 nm for wt (n = 1 animal, 58 synapses) and 206.2 ± 71.4 nm
forAtp6ap2Camk2aCre/0 (n = 2 animals, 84 synapses), unpaired t-test,
Figure 6. Presynaptic knockdown of Drosophila ATP6AP2 disrupted synapse morphology and ultrastructural organization and affected BRP transport. (A–C) Quantitative
assessment of morphological parameters at the NMJ upon presynaptic ATP6AP2 knockdown (ATP6AP2RNAi1: UAS-Dicer-2/+; elav-Gal4/UAS-ATP6AP2RNAi1, ATP6AP2RNAi2:
UAS-Dicer-2/+; elav-Gal4/UAS-ATP6AP2RNAi2). The area of synaptic terminals, number of active zones and number of satellite boutons, as quantiﬁed based on NMJs
immunostained with anti-DLG (postsynaptic) and anti-BRP (active zone) markers (see Supplementary Material, Fig. S6), were normalized against appropriate genetic
background controls (UAS-Dicer-2/+; elav-Gal4/+). Bar graphs represent averages, and error bars represent SEM. Signiﬁcance was determined using a one-way ANOVA
and post hoc Tukey’s multiple comparison test. *P < 0.5, **P < 0.01, ***P < 0.001. (D) Representative NMJs of control, ATP6AP2RNAi1 and ATP6AP2RNAi2 animals labelled with
anti-synaptotagmin (anti-syt). This marker readily revealed evident abnormal bouton morphology and a highly increased number of satellite buttons (arrowheads) in
both ATP6AP2 knockdown conditions. (E) Ultrastructural analysis of ATP6AP2RNAi1 versus control synaptic boutons showed the appearance of large multivesicular
body-like structures (asterisk) and (F) abnormal T-bar morphology. (E and F) Images were acquired at 15 000× and 30 000× magniﬁcation, respectively. (G) Motor axons
of control and ATP6AP2RNAi1 animals were immunolabelled with anti-HRP (red) and anti-BRP (nc82 anti-bruchpilot, green). ATP6AP2RNAi1 showed abnormal
accumulation of the presynaptic marker BRP, which is indicative of axonal transport defects. All analyses were performed in third instar larvae muscle 4 type 1b NMJs.
P = 0.0062, Fig. 7U] and an even stronger reduction in the mean
width in thehippocampus [meanwidth: 243.5 ± 84.3 nmforwt (n= 1
animal, 45 synapses) and 174.7 ± 70.9 nm for Atp6ap2Camk2aCre/0
(n = 2 animals, 81 synapses), unpaired t-test, P < 0.0001, Fig. 7V]
of Atp6ap2Camk2aCre/0 mice compared with wt mice. In parallel,
we observed an increased number of split synapses, correspond-
ing to the presence ofmore than one synapsewithin a single syn-
aptic terminal/spine contact, in the cortex and hippocampus of
Atp6ap2Camk2aCre/0 mice, whereas split synapses were only rarely
observed in the cortex and hippocampus of wt mice (Fig. 7M–P).
In contrast, we did not detect any change in the size of synaptic
vesicles (data not shown). However, in synaptic buttons, we
noticed the presence of atypically elongated vesicles whose
diameters were similar to that of synaptic vesicles (Fig. 7N).
Atp6ap2Camk2aCre/0 transcriptome deregulation
correlates with Atp6ap2Camk2aCre/0 mouse
behavioural and physiological phenotypes
As a global approach to assess ATP6AP2-associated brain pathol-
ogy and to identify processes dependent on ATP6AP2 unbiasedly,
we performed genome-wide transcriptome proﬁling by mRNA-
seq analysis of the Atp6ap2Camk2aCre/0 hippocampus, the brain
area most affected in our mouse model, at postnatal day 30. To
study the changes inmaturemRNA levels, we compared the exon
reads of transcripts in wild-type and mutant samples (DEseq al-
gorithm, P < 0.05, Fig. 9) and identiﬁed 224 up-regulated and 177
down-regulated genes in mutant hippocampi compared with
wt. To determinewhich brain cell typewas affected by those dys-
regulations directly or indirectly, we performed enrichment tests
of either astrocytes, neuronal- or oligodendrocyte-speciﬁc mar-
kers (34) on the set of up- and down-regulated genes (Fig. 9A).
Interestingly, the up-regulated genes were highly enriched in
oligodendrocyte-expressed genes (hypergeometric test, P < 2.2E-
12) and simultaneously had no enrichment for neuronal markers.
In contrast, down-regulated geneswere enriched inneuronalmar-
kers (P < 1.2E-6) but only slightly enriched in oligodendrocytemar-
kers. Then, we performed GO/KEGG/UniProt enrichment
analyses of the lists of up- and down-regulated genes, using a
Benjamini cut-off of P < 0.05. The lists of up- and down-regulated
genes per GO term are presented in Supplementary Material,
Excel File S1 for enrichment calculated in the DAVID website
Figure 7. Axonal and neuronal degeneration in the Atp6ap2Camk2aCre/0 mouse cortex and hippocampus. Electron microscopy analysis of adult cortical and hippocampal
sections revealed several alterations in the Atp6ap2Camk2aCre/0 mice. (A–D) We observed the presence of degenerating neurons (black arrows) in the cortex and
hippocampus of Atp6ap2Camk2aCre/0 mice (B and D, respectively) compared with the morphology of neurons from the cortex and hippocampus of wt mice (A and C,
respectively). Image B shows neurons at different stages of degeneration. Scale bar: 5 µm. (E–L) Myelinated axons showed decreased myelin thickness owing to a
reduction in the number of myelin sheaths in both the Atp6ap2Camk2aCre/0 cortex and hippocampus (F and H, respectively) compared with the number of myelin
sheaths in the cortex and hippocampus of wt mice (E and G, respectively). Some axons also had disturbed microtubules (F). A considerable number of axons were
degenerating (white arrows) or already disappeared in Atp6ap2Camk2aCre/0 mice (J and L, respectively). Scale bars: 1 µm (E–H), 2 µm (I–L). (M–P) High-magniﬁcation
images showed the normal morphology of synapses from the cortex and hippocampus of wt mice (M and O, respectively) and the altered morphology of synapses
from the cortex and hippocampus of Atp6ap2Camk2aCre/0 mice with synapse width reduction and synapse splitting (N and P, respectively). Some synapses in mutant
mice presented strange elongated vesicles (arrowhead) (N) that were absent in the synapses of wt mice (M). The number of vacuoles (asterisk) increased in the cortex
and hippocampus of Atp6ap2Camk2aCre/0 mice (N and P, respectively) compared with the number of vacuoles in the cortex and hippocampus of wt mice (M and O,
respectively). Scale bar: 500 nm. Analysis of high-magniﬁcation electron microscopy images of synapses from wt and Atp6ap2Camk2aCre/0 mice conﬁrmed the reduction
in the synapses width in the cortex (Q) and hippocampus (R) of mutant mice. Bar graphs represent averages, and error bars represent SEM. Signiﬁcance was
determined using unpaired non-parametric t-test. **P < 0.01, ***P < 0.001 versus wt.
and in Supplementary Material, Excel File S2 for enrichment cal-
culated in the Bingo tools for Cytoscape. A visual representation
of the GO enrichment for the up- and down-regulated genes is
shown in Figure 9B, together with the lists of individual genes
underlying the primary enrichments. The strongest enrichments
for the up-regulated genes were related to myelination, regula-
tion of action potential and cellular ion homeostasis. Among
those up-regulated genes, 17 genes were speciﬁcally linked
to the myelin sheath (P < 2.2E-5). Thirteen of these genes were
predominantly expressed in oligodendrocytes compared with
Figure 8. Deletion of ATP6AP2 leads to defective autophagy in neurons. Immunohistochemical analysis of adult mouse brain sections using the autophagy markers p62
and UBQLN2 revealed perturbed autophagy in the Atp6ap2Camk2aCre/0 mouse cortex and hippocampus. (A–H) Immunohistochemical analysis revealed increased p62
staining in Atp6ap2Camk2aCre/0 mice. The region most affected was the CA3 region, with massive increases in p62 staining and cell death (D) that were not observed in
the CA3 region of wt mice (C). The DG was also highly affected, with a considerable increase in p62 staining (B). The CA1 (F) and the cortex (H) were less affected, with
small increases in p62 staining compared with p62 staining in those regions in wt mice (A, E and G, respectively). (I–P) Immunohistochemistry with the marker
UBQLN2 also showed increases in staining, with a massive increase in the CA3 area (L), a strong increase in the DG (J) and a small increase in the CA1 area (N) and
cortex (P) compared with UBQLN2 staining in those regions in wt mice (K, I, M and O, respectively). Scale bar (A–P): 100 µm. Immunohistochemical analysis of
Drosophila adult brains using the p62 orthologue Ref(2)p as autophagy marker in pan-neuronally induced ATP6AP2 knockdown (ATP6AP2RNAi1: UAS-Dicer-2/+; elav-Gal4/
UAS-ATP6AP2RNAi1, ATP6AP2RNAi2: UAS-Dicer-2/+; elav-Gal4/UAS-ATP6AP2RNAi2) and their appropriate genetic background controls. Representative images are shown for
the indicated genotypes in (Q–T). In ATP6AP2 knockdown brains, a signiﬁcant increase in the intensity of Ref(2)p signal is observed, revealing widespread autophagy
defects. Scale bar (Q–T): 40 µm. A minimum of 14 images was collected per genotype. Quantitative assessments and statistical analysis of the images are shown in
Supplementary Material, Figure S7.
other cell types (Fig. 9B), suggesting that the physiological equi-
librium of oligodendrocytes was altered in Atp6ap2Camk2aCre/0
mice. In total, 18 genes were related to action potential and cel-
lular ion homeostasis, and 2 of them were neuron-speciﬁc
genes. Among the observed enrichments of the up-regulated
genes, 12 genes affecting motor behaviour (P < 9.1E-3) were
present (Fig. 9B), including primarily neuron-expressed genes.
Down-regulated genes showed a striking enrichment in the cel-
lular components related to vesicles, synapses and dendrites. In
particular, we found 13 genes related to membrane-bound vesi-
cles (P < 3.4E-3), including 5 neuronal markers. Interestingly,
among the down-regulated genes appeared the ATP6V0A1
gene, which codes for the A1 subunit of the V0 proton-transloca-
tion domain of V-ATPase, suggesting that Atp6ap2 deletion in the
hippocampal glutamatergic neurons would perturb the expres-
sion of its binding partner. In conclusion, the up- and down-regu-
lated genes highlight molecular processes such as myelination,
action potential regulation, motor behaviour and membrane-
bound vesicles, which are in agreement with the primary pheno-
types that we were able to associate with the mouse and ﬂy
ATP6AP2models.
Discussion
Here, we investigated the role of ATP6AP2 in the nervous system
of two animal models, mouse and Drosophila. The identiﬁed phe-
notypes are largely consistent in both organisms and suggest an
essential role of ATP6AP2 in nervous system development, basal
synaptic transmission and cognitive functions.
ATP6AP2 was found to play an evolutionarily conserved role
in the regulation of spontaneous motor activity. MB-speciﬁc
ATP6AP2 knockdown in Drosophila caused elevated activity in
response to stimulation, andmicewithAtp6ap2 deletion in gluta-
matergic neurons exhibited increased spontaneous locomotor
and vertical activities in several tests. ATP6AP2 is also crucial
for short- and long-term memory, as shown in the contexts of
Drosophila courtship conditioning and mouse fear conditioning.
The fear conditioning defect observed in the mouse model
could be attributed to the defective hippocampal-to-basolateral
amygdala transmission. Indeed, the efﬁciency at hippocampal
projections to the basolateral amygdala was shown to be of
crucial importance for the aversive conditioned response in
mice (28).
At the cellular level, ATP6AP2 appears to play a crucial and
pleiotropic role at variousmembrane compartments. In neurons,
it localized primarily to the ER and to a lesser extent to lysosomes
and autophagosomes. Its deletion in mouse glutamatergic neu-
rons induced an increase in the number vacuoles in cortical
and hippocampal neurons. Similarly, its knockdown inDrosophila
eye led to vacuolated photoreceptor-surrounding pigment cells
and induced ectopic multivesicular body-like membrane com-
partments in photoreceptor neurons. In addition, we observed
strong accumulation of two autophagy substrates, p62 and
UBQLN2, in the cortex and hippocampus of Atp6ap2Camk2aCre/0
mice. These results suggest a defect in lysosome-mediated pro-
tein degradation and, thus, autophagic activity. Interestingly,
this defect corresponds to the situation observed in the Parkin-
sonism and spasticity (XPDS) patient brains where Korvatska
Figure 9.Transcriptome analysis of theAtp6ap2Camk2aCre/0mousehippocampus showed the deregulation of genes related tomyelination, behaviour andmembrane-bound
vesicles. (A) Atp6ap2Camk2aCre/0 hippocampus RNA-seq. The pie chart shows the number of dysregulated genes, with P < 0.05 (DEseq2). The bar charts display the
enrichments of up-regulated and down-regulated genes with either neuronal- or oligodendrocyte-speciﬁc markers (i.e. genes expressed 16-fold higher in the latter
cells compared with other cell types). (B) Visual representation of the GO enrichments for the Atp6ap2Camk2aCre/0 up-regulated and down-regulated genes. The network
connectivity is shaped using an overlap score that highlights term similarities; thicker edges represent higher similarity between connected terms/functions. The
single genes underlying the primary enrichments are listed in the grey shaded boxes; the gene names are coloured in blue (light blue) when expressed 16-fold (4-fold)
more times in oligodendrocytes compared with other cell types. Neuronal markers are coloured in red (light red) using the same principle.
and collaborators (5) observed a massive accumulation of p62/
SQSTM1. Autophagy defects have also been observed in cardio-
myocyte and podocyte conditional Atp6ap2mouse models (12–14).
In Drosophila, Hermle and collaborators (15) also suggested a
role for ATP6AP2/(P)RR in protein degradation. We propose that
one primary function of ATP6AP2 in neurons is to regulate auto-
lysosomal material digestion. This hypothesis is supported by
the tight physical and functional association of ATP6AP2 with
V-ATPase and by the identiﬁcation of V-ATPase V0 subunit A1
among the down-regulated genes in Atp6ap2Camk2aCre/0 hippo-
campi. Indeed, the V-ATPase complex is amajor element of lyso-
somes and autolysosomes, where it acidiﬁes the vesicle lumen.
Vesicle acidiﬁcation is required for the activation of lysosomal
enzymes. The absence of Atp6ap2 in glutamatergic neurons
may induce a perturbation of V-ATPase function in lysosomes,
resulting in defective lysosome acidiﬁcation and, thus, defective
activation of lysosomal enzymes and defective digestion of lyso-
somal substrates.We suggest that this deregulated autophagy in-
duces the axonal and neuronal degeneration observed in the
cortex and hippocampus of Atp6ap2Camk2aCre/0mice. Indeed, neu-
rons, particularly axons, are well known to be highly sensible to
autophagy dysregulation, resulting in degeneration (35).
One unexpected ﬁnding of this study is the consequence of
Atp6ap2 neuronal inactivation on myelin. Indeed, Atp6ap2Camk2aCre/0
miceshoweddecreased amount ofmyelin layers and reduction in
the total thickness of myelin sheath in the cortex and hippocam-
pus. In addition, we identiﬁed the enrichment of dysregulated
genes expressed predominantly in oligodendrocytes and impli-
cated in regulating myelination. Nevertheless, the decreased
thickness of the myelin sheath in Atp6ap2Camk2aCre/0 mice seems
to be a secondary effect ofAtp6ap2 loss in glutamatergic neurons,
and the up-regulation of oligodendrocytemyelination genesmay
be a compensatory effect of oligodendrocytes to counteract de-
creased myelination. Myelin deﬁcits or defective glial/neuronal
interactions have already been found in neurodevelopmental
disorders including autism spectrum disorder (36) and Rett syn-
drome (37) and in adult-onset neurodegenerative diseases in-
cluding Parkinson’s disease (38).
At the synapse level, we demonstrated both morphological
and functional aberrations in mouse and Drosophila models. In
mouse, we observed reduced synapse width in the cortex and
hippocampus of Atp6ap2Camk2aCre/0 mice with synapse splitting.
Similarly, pan-neuronal ATP6AP2 knockdown in Drosophila led
to a reduction in presynaptic terminal size, with abnormal organ-
ization of boutons and an increased number of satellite boutons.
We also observed defects in subsynaptic organization, including
the presence of atypically elongated vesicles in the mouse cor-
tical and hippocampal presynaptic compartments and abnormal
active zones in presynaptic terminals of Drosophila NMJs. These
converging data suggest a role for ATP6AP2 in synaptic vesicle
homeostasis, which is in agreement with a close functional rela-
tionship of ATP6AP2 with V-ATPase and its role in synaptic
vesicle acidiﬁcation. V-ATPase is required for synaptic vesicles
loading with neurotransmitters (39). In addition, the V0 domain
ofV-ATPase is part of a complex involved in the fusion of synaptic
vesicles with the plasma membrane and thus participates in the
regulation of neurotransmitter release (40). Poea-Guyon and
collaborators (41) also proposed that V-ATPase, as a sensor of in-
travesicular pH, informs the exocytosis machinery of the con-
tents of synaptic vesicles to avoid exocytosis of unloaded
vesicles. The absence of ATP6AP2 could perturb V-ATPase func-
tion in synaptic vesicles and thus disturb synaptic vesicle loading
and/or fusion. In addition tomorphological alteration,wealso pro-
vided evidence for defective synaptic transmission. In Drosophila,
ATP6AP2 knockdown in photoreceptor neurons caused synaptic
transmission defects. In mouse, we showed a decreased release
probability of excitatory synapses at the hippocampal to basolat-
eral amygdala connections. However, the reduced presynaptic
release probability could also be partly explained by the reduced
number of excitedﬁbres owing to axonal degeneration. Altogether,
our results conﬁrm an important role for ATP6AP2 in regulating
synaptic size, connections and synaptic vesicles, with conse-
quences for presynaptic transmission.
One family with ATP6AP2mutation was reported to have epi-
lepsy, hence, we tested the mouse model for epilepsy susceptibil-
ity.Wedidnot observed spontaneous epilepsy inAtp6ap2Camk2aCre/0
mice and mutant mice even had reduced susceptibility to epi-
lepsy induced by PTZ administration. In our mouse model,
Atp6ap2 is deleted only in Camk2a-positive neurons, i.e. exci-
tatory neurons, but not in inhibitory neurons. Thus, consider-
ing the important role of inhibitory neurons in preventing
epilepsy, we cannot exclude that the absence of epilepsy
could be due to the absence of Atp6ap2 deletion in the inhibi-
tory neurons.
Transcriptome analysis of Atp6ap2Camk2aCre/0 hippocampi re-
vealed up-regulated genes related to myelination, motor behav-
iour and action potential regulation and down-regulated genes
implicated in membrane-bound vesicles, showing a striking cor-
relation with the behavioural and physiological phenotypes ob-
served in mouse and ﬂy. This ﬁnding suggests that some of the
observed phenotypes could be linked to aberrant signalling con-
verging onto transcription. The effects of Atp6ap2 deletion on
transcription regulation may be direct or indirect. Atp6ap2 dele-
tion could have indirect effect on gene transcription as suggested
for the transcriptional changes observed in genes implicated in
myelination mainly expressed in oligodendrocyte; however,
this deletion could also affect transcriptional responses directly,
e.g. via the Wnt signalling pathway or the MAP kinases ERK1/2
pathway. Indeed, several studies have implicated ATP6AP2 in
Wnt signalling (16–18,21). Notably, with its smaller synaptic
terminals andmanysatellite boutons,Drosophila ATP6AP2 knock-
down synapses showed striking similarities tomutants defective
in Wnt signalling (42–44). In addition, Atp6ap2Camk2aCre/0 mice
showed partially overlapping behavioural phenotypes with
Wnt/β-catenin mouse models because down- or up-regulation
of the Wnt pathway (with injection of the Wnt antagonist
Dkkk-1 orWnt1 peptide) affected contextual and cued fearmem-
ory, spatial memory in the Morris water maze and novel object
recognition but did not affect baseline locomotor activity and
anxiety behaviour (45). ATP6AP2, also known as (pro)renin recep-
tor, is also involved in the renin-angiotensin system (RAS). Acti-
vation of ATP6AP2 by (pro)renin binding could trigger the
activation of two independent pathways, one resulting in the
generation of angiotensin at the cell surface and the activation
of its receptors and signalling pathways (including the MAP ki-
nases ERK1/2 pathway) and another resulting in direct activation
of the MAP kinases ERK1/2 pathway and the promyelocytic leu-
kaemia zinc ﬁnger transcription factor (PLZF) by activated
ATP6AP2 (46–49). It has been shown that the RAS plays an import-
ant role in brain physiological processes such as learning, mem-
ory and cognitive functions (50). Moreover, several members of
MAP kinases ERK1/2 pathway have been implicated in ID, includ-
ing RSK2, which is responsible for the Cofﬁn Lowry syndrome.
Further studying the role of ATP6AP2 in transcription regulation
and, speciﬁcally, to what extent the synaptic and behavioural
phenotypes observed in Drosophila and mouse models result
from abnormal Wnt and/or MAP kinases ERK1/2 signalling will
be extremely interesting.
We demonstrated that ATP6AP2 depletion in Drosophila and
mouse induced behavioural, neuronal and synaptic phenotypes
that lead to cognitive impairment and neurodegeneration,
which greatly recapitulates the phenotypes associated with
ATP6AP2mutations in human. The twoATP6AP2mutations iden-
tiﬁed in humans so far are splicingmutations, both leading to the
skipping of the exon 4 of the gene (2,5). This results in signiﬁcant
overexpression (∼50%) of a 150-bp minor splice isoform, which
produces a protein with an internal deletion of 32 amino acids,
and concomitant reduction of the major full size transcripts
(2,5). Contrepas and collaborators suggested that ATP6AP2 pro-
tein lacking exon 4 (Δ4 ATP6AP2) would act as a dominant nega-
tive through dimerization with ATP6AP2 wild-type proteins (51).
In XPDS patients, a reduction of the total amount of ATP6AP2 pro-
teins was observed in the brain (5). In contradiction, another
ATP6AP2 mutation was identiﬁed in a male within a cohort of
6500 sequenced control exomes (3). This mutation is also a spli-
cing mutation affecting the last exon of the gene; however, it has
never been validated and the consequences of the mutation re-
main unclear. As we demonstrated that ATP6AP2 deletion in
Drosophila andmouse has drastic consequences on neurons, sup-
porting its involvement as a causative gene for ID and Parkinson-
ism, we suggest that ATP6AP2 should be considered when
screening patients with X-linked intellectual disabilities with
epilepsy and/or Parkinsonism with spasticity (2,3,5). Indeed, an-
other member of the V-ATPase complex, ATP6V0A2, has also
already been implicated in ID (23).
Materials and Methods
Drosophila stocks and genetics
Conditional RNAi lines targeting ATP6AP2 (stocks 105281 and
5830, referred to as UAS-ATP6AP2RNAi1 and UAS-ATP6AP2RNAi2, re-
spectively) and UAS-Vha100-1RNAi (22924), genetic background
controls (60100, 60000) and UAS-Dicer-2 (60008, 60009), were ob-
tained from the Vienna Drosophila RNAi Centre (VDRC, Vienna,
Austria). GMR-Gal4 (1104) and elav-Gal4 (8760) strains were ob-
tained from the Bloomington Drosophila Stock Center (Indiana
University). Drivers GMR-Gal4; UAS-Dicer-2, act-Gal4/CyO-GFP;
UAS-Dicer-2/CyO and UAS-Dicer-2; elav-Gal4 were assembled in-
house. The mushroom body-speciﬁc driver w+,UAS-Dicer-2; 247-
Gal4 was a gift from K. Keleman. Flies were cultured according
to standard procedures and raised at 28°C unless indicated
otherwise.
Drosophila phototaxis
UAS-ATP6AP2RNAi1, UAS-ATP6AP2RNAi2, UAS-Vha-100-1RNAi lines
and their genetic background control lines were crossed with
GMR-Gal4;UAS-Dicer-2 virgins and raised at 28°C. In the fast
phototaxis assay (52,53), a countercurrent apparatus was used
to fractionate genotypes among six tubes according to their vis-
ual activity. The phototaxis index (PI) is calculated as ∑i*Ni)/N,
where N is the number of ﬂies, i is the tube number and Ni is
the number of ﬂies in the ith tube. The average PI and standard
deviation were calculated from three independent experiments
on different test days. Assays were performed as described
previously (22).
Drosophila electroretinograms
UAS-ATP6AP2RNAi1, UAS-ATP6AP2RNAi2 and their control lines
were crossed with GMR-Gal4;UAS-Dicer-2 virgins and raised at
28°C. ERG recordings were performed as described previously
(27). Flies were tested at day 1 post-eclosion. In total, 8–10 ﬂies
were used per genotype and the average of 5 recordings is
presented.
Drosophila courtship conditioning
Courtship conditioning (25) was performed as described previ-
ously (24) using males of the genotypes w+,UAS-Dicer-2/Y; 247-
Gal4/UAS-ATP6AP2RNAi1; +/+ and w+,UAS-Dicer-2/Y; 247-Gal4/+;
+/+ (control). Males were collected at eclosion and kept in isola-
tion until 4 days of age. Then, the males were trained by pairing
with a single pre-mated female for 1 h to induce short-term
memory and for 7 h to induce long-termmemory. After training,
themales were isolated for 1 h (short-termmemory, STM) or 24 h
(long-termmemory, LTM), transferred to a 1-cm diameter cham-
ber and ﬁlmed for 10 min in the presence of a new pre-mated fe-
male. The courtship behaviour of male ﬂies towards females was
quantiﬁed using Actual FlyTrack software (Actual Analytics Ltd).
Themean courtship indexes (CI, the percentage of time spent on
courtship during a 10-min interval) of trained males and of so-
cially naïve males were used to calculate the learning index (LI),
which is deﬁned as the per cent reduction in mean courtship ac-
tivity in trained males compared with naïve males; LI = (CInaive–
CItrained)/CInaive. For all conditions, male–female pairs were ana-
lysed on four different test days, and the data were pooled. For
non-parametric statistical comparison of the STM and LTM LIs
of ATP6AP2 knockdown and control ﬂies, we used a custom R
script to perform bootstrapping as described previously (54).
Brieﬂy, CI values were randomly sampled with replacement to
generate 10 000 hypothetical LIs, which were used to determine
the 95% conﬁdence interval of the difference between the index
of the control and the index of the knockdownand the probability
that this difference is >0.
Mouse lines, ethical statement and genotyping
The Atp6ap2tm1.ICS conditional knockout mouse line (noted At-
p6ap2cKO) was generated at the Institut Clinique de la Souris
(ICS; llkirch, France) in collaboration with Merck & Co and pur-
chased via Taconic (www.taconic.com). The targeting vector
was constructed by the successive cloning of PCR products and
contained 4.2-kb 5′ and 3.3-kb 3′ homology arms and aNeomycin
selection cassette. Two loxP sequences were located 682 bp be-
fore exon 2 and 449 bp after exon 2 (Supplementary Material,
Fig. S1). The linearized construct was electroporated into
C57BL/6N (B6N)mouse embryonic stem (ES) cells. After selection,
targeted clones were identiﬁed by PCR using external primers
and further conﬁrmed by Southern blot with a Neo internal
probe and with a 5′ external probe (data not shown). A positive
ES clone was injected into BALBc/J blastocysts, and male chi-
maeras derived from this procedure gave germline transmission.
The resulting linewas veriﬁed by PCR using external primers and
further conﬁrmed by Southern blot with a Neo internal probe.
Progeny mice were on the B6N background.
The ﬂipped Neo selection cassette was removed in vivo by
breeding the chimaeras directly with a Flp deleter line (57). The
Flp transgene was segregated by a further breeding step. We
used the transgenic Tg(Camk2aCre)4Gsc mouse line (26), as a
glutamatergic neuron-speciﬁc Cre driver to inactivate the
Atp6ap2 gene spatially and temporally. A Tg(Camk2CreERT2)Ics
mouse line was also generated at ICS and used to evaluate the
effects of Atp6ap2 excision in adults after tamoxifen (Tam)
injection. For the study, we used males that have only one
copy of Atp6ap2<cKO/+> gene, i.e. ﬂoxed Atp6ap2, and either
hemizygote for Tg(Camk2aCre)4Gsc/0 or Tg(Camk2CreERT2)Ics.
The corresponding males were noted Atp6ap2Camk2aCre/0 or
Atp6ap2Camk2aCreERT2/0 as mutant and compared with wild-type
littermate (wt) as controls.
The mice were housed in groups (2–4 per cage) and allowed 2
weeks of acclimation in the phenotyping area with a controlled
temperature (21–22°C) under a 12–12 light/dark cycle (lights on
at 7:00 a.m.), with food andwater available ad libitum. Behavioural
experiments started at 13 weeks old and included a pipeline of 12
tests. The behavioural pipelinewas performed in agreementwith
the EC directive 2010/63/UE86/609/CEE and was approved by
the local animal care, use and ethic committee of the IGBMC
(Com’Eth) under accreditation number (2012–139).
Mutant mice were identiﬁed by PCR analysis of tail genomic
DNA. Forward (5′ AGCACTCTCTTCCAGGTATGTTGTG 3′) and re-
verse (5′ CTGGATCCCGGAGCATGGGTAAAGG 3′) primers set 1
generate a 280-bp band from the wild-type allele (Atp6ap2wt)
and a 330-bp band from the conditional (Atp6ap2cKO) allele; for-
ward (5′ CAGGTGTGCTGCTATTAATAGG 3′) and reverse (5′ GCCC-
CTCTCTTACAGTTCTATCAGT 3′) primers set 2 generate a 289-bp
band from the Atp6ap2cKO allele and a 179-bp band from the
wild-type (wt) allele; forward (5′ AGCACTCTCTTCCAGGTATG
TTGTG 3′) and reverse (5′ GCCCCTCTCTTACAGTTCTATCAGT 3′)
primers set 3 generate a 1640-bp, a 326-bp and a 1480-bp band
from the Atp6ap2 cKO, KO and wt alleles, respectively.
Mouse behavioural analysis
We initially performed a thorough behavioural characterization of
Atp6ap2Camk2aCre/0mice. A cohort of 12 wt and 12 Atp6ap2Camk2aCre/0
mice were submitted to a battery of tests to evaluate a wide range
of CNS and PNS functions or their pathologies: circadian activity
(13weeks), object recognition (14weeks), gross neurological exam-
ination grip strength and rotarod (15 weeks), Y maze and prepulse
inhibition (16 weeks), fear conditioning (17 weeks), social recogni-
tion (23 weeks), Morris water maze (26 weeks) and hot plate (29
weeks). The temporally controlled mutants (Atp6ap2Camk2aCreERT2/0,
11 wt and 10mutants) were also submitted to selected behavioural
tests [circadian activity (31 weeks), fear conditioning and shock
threshold (32 weeks), water maze and hot plate (33 weeks)] to
evaluatewhether the potential phenotypes observed in constitu-
tively mutants are also found when Atp6ap2 deletion is induced
in adults after tamoxifen administration. Tamoxifen, which is
used to activate the CreERT2 fusion protein, was dissolved in a
mixture of ethanol/oil and administered twice a day for ﬁve
consecutive days. The mice were allowed 2 months to recover
after Tam treatment and then transferred for phenotyping and
behavioural testing.
Gross neurological examination: the general health and basic
sensory motor functions of the mice were evaluated using a
modiﬁed SHIRPA protocol (EMPRESS, eumorphia.org, 55). This
protocol provides an overview of the physical appearance, body
weight, body temperature, neurological reﬂexes and sensory abil-
ities of the mice.
Circadian activity and ingestive behaviours: spontaneous loco-
motor activity and rears were measured using individual boxes
equipped with infrared captors. The quantities of water and food
consumedweremeasuredduring the testperiodusinganautomated
pellet feeder and a lickometer (Imetronic, Pessac, France). The mice
were tested for 35 h tomeasure apparatushabituation andnocturnal
and diurnal activities. The results are expressed per 1-h period.
The open-ﬁeld test:micewere tested in automated openﬁelds
(Panlab, Barcelona, Spain); each ﬁeld was divided virtually into
central and peripheral regions. The open ﬁelds were placed in a
room homogeneously illuminated at 70 Lux. Each mouse was
placed in the periphery of the open ﬁeld and allowed to explore
the apparatus freely for 30 min with the experimenter out of
the animal’s sight. The distance travelled, the number of rears
and time spent in the central and peripheral regions were re-
corded over the test session. The number of entries and the per-
centage of time spent in centre area are used as indexes of
emotionality/anxiety.
Social recognition test: this task is used to evaluate the prefer-
ence of amouse for a congener comparedwith an object placed in
an opposite compartment. The apparatus is a transparent run-
way composed of a central starting box and two goal boxes delim-
ited by a sliding grid at each extremity of the runway. Testingwas
performed for two consecutive days. On the ﬁrst day, fresh bed-
ding was placed in the goal boxes. The mouse was placed in the
start box for 30 s and then allowed to explore the apparatus freely
for 10 min to attenuate their emotionality and to evaluate any po-
tential preference between the two compartments. On the se-
cond day, a B6N congener of the same gender was placed in
one goal box, and an object (dice for example) was placed in the
opposite goal box. The mouse was placed in the start box for 30 s
and then allowed to explore the apparatus freely for 10 min. The
position of the congener and object boxes was counterbalanced
to avoid any potential spatial preference. The duration of explor-
ation of each goal box (when the mouse is snifﬁng the grid deli-
miting the goal box) was measured, and the percentage of time
the mouse took to explore the congener was used as an index
of social preference (recognition preference). The number of
entries, the time spent in each goal arm and the vertical activity
in each arm were also measured. The social recognition index (SR)
is deﬁned as [time congener/(time object + time congener)] × 100.
Object recognition task: the object recognition task was per-
formed in automated open ﬁelds (see above). The open ﬁelds
were placed in a room homogeneously illuminated at 70 Lux at
the level of each open ﬁeld. The objects to be discriminated
were a glass marble (2.5 cm diameter) and a plastic dice (2 cm).
The animals were ﬁrst habituated to the open ﬁeld for 30 min.
The next day, they were submitted to a 10-min acquisition trial
during which they were placed in the open ﬁeld in the presence
of Object A (marble or dice). The time the animal took to explore
Object A (when the animal’s snout was directed towards the ob-
ject at a distance of ≤1 cm) was recorded manually. A 10 min re-
tention trial was performed 3 h later. During this trial, Object A
and Object B are placed in the open ﬁeld, and the times tA and
tB that the animal takes to explore the two objects are recorded.
The recognition index (RI) is deﬁned as [tB/(tA + tB)] × 100.
Auditory startle reﬂex reactivity and prepulse inhibition:
acoustic startle reactivity and prepulse inhibition (PPI) of the star-
tle reﬂex were assessed in a single session using standard startle
chambers (SR-Lab Startle Response System, San Diego Instru-
ments, USA). Ten different trial types were used: acoustic startle
pulse alone (110 db); eight different prepulse trials in which ei-
ther 70, 75, 85 or 90 dB stimuli were presented alone or preceded
the pulse and ﬁnally one trial (NOSTIM) in which only the back-
ground noise (65 dB) was presented to measure the baseline
movement in the Plexiglas cylinder. In the startle pulse or pre-
pulse alone trials, the startle reactivity was analysed, and in the
prepulse plus startle trials, the amount of PPI was measured and
expressed as a percentage of the basal startle response.
Pavlovian fear conditioning: polymodal operant chambers
(Coulbourn Instruments, Allentown, PA) were used for this ex-
periment. Each chamber (18.5 × 18 × 21.5 cm) consisted of alu-
minium side walls and Plexiglas rear and front (the door) walls.
A loudspeaker and a bright light constituted the sources of the
cues during conditioning and cue testing. The general activity of
the animals was recorded through the infrared cell placed at the
ceiling of the chambers and was recorded directly on a PC com-
puter using Graphic State (Coulbourn). For conditioning, the
mice were allowed to acclimate for 4 min, and then a light/tone
(10 kHz) CS was presented for 20 s and co-terminated by a mild
(1 s, 0.4 mA) footshock (US). The mice were returned to their
home cages 2 min later. Testing was performed 24 h following
the conditioning session. Testing for the context was performed
in themorning. Themousewas placed back into the same cham-
ber that was used for the conditioning and allowed to explore for
6 min without presentation of the light/auditory CS. Testing for
the cue was performed in the afternoon (∼5 h after the context
testing). The contextual environment of the chambers was chan-
ged (wall colour, odour and ﬂoor texture). The mouse was placed
in the new chamber, allowed tohabituate for 2 min, and thenpre-
sented with light/auditory cues for 2 min. This sequence was re-
peated once again. At the end of the testing, the animals were
returned to their home cages.
Mouse electrophysiology
Stereotaxic viral infections: adeno-associated viruses (AAV2/9.
CAG.ChR2-Venus.W.SV40-p1468, ref Addgene-20071, 5.82E12
vector genomes (vg)/ml) and AAV-Cre (AAV2/1.CMV.HI.eGFP-
Cre.WPRE.SV40, PennVector P1415, 1.33E13 vg/ml)were packaged
at the University of Pennsylvania Vector Core. Seven-week-old
mice (over 20 g) were prepared for stereotaxic injection. Before-
hand, the mice were treated with buprenorphine (0.1 mg/kg,
i.p.) and positioned in a stereotaxic apparatus (David Kopf Instru-
ments, Tujunga, CA) under continuous anaesthesia with isoﬂur-
ane. During the surgery, the mice were warmed on a 33–35°C
heating pad. The virus was bilaterally pressure-injected through
glass pipettes (Hirschmann Laborgerate, ringcaps, tips were
pulled from OD 30–50 µm) using a Picospritzer (Parker, Co). The
positions of bregma and lambda points were deﬁned and ad-
justed to the same horizontal level. Injection coordinates for
the caudal hippocampus were [AP] −3.1–3.3 mm, [ML] ±3.2–
3.4 mm and [DV] −4.0 mm.
Acute slice preparations: AAV-infectedmicewere used to pre-
pare coronal basolateral amygdala (BLA)-containing acute slices.
Owing to animal age (3 months old at the time of dissection), we
used the ‘protective recovery method’ described at http://www.
brainslicemethods.com. Brieﬂy, mice were anesthetised with a
mixture of ketamine/xylazine (100 and 10 mg/kg, respectively)
and cardiac-perfused with ice-cold, oxygenated (95% O2, 5% CO2)
cutting solution (NMDG) containing 93 m NMDG, 93 m HCl,
2.5 m KCl, 1.2 m NaH2PO4, 30 m NaHCO3, 25 m glucose,
10 mMgSO4, 0.5 mCaCl2, 5 m sodiumascorbate, 3 m sodium
pyruvate, 2 m thiourea and 12 m N-acetyl--cysteine (pH 7.3–
7.4, with osmolarity of 300–310mOsm). The brains were removed
rapidly and placed in the ice-cold and oxygenated NMDG cutting
solution described earlier. Coronal slices (300 μm) were prepared
using a vibratome (VT1200S, Leica Microsystems, USA) and trans-
ferred to a 32°C incubation chamber containing the same NMDG
cutting solution. After the slides were incubated, they were main-
tained at room temperature in oxygenatedmodiﬁed ACSF contain-
ing 92 m NaCl, 2.5 m KCl, 1.2 m NaH2PO4, 30 m NaHCO3,
20 m HEPES, 25 m glucose, 2 m MgSO4, 2 m CaCl2, 5 m so-
dium ascorbate, 3 m sodiumpyruvate, 2 m thiourea and 12m
N-acetyl--cysteine (pH 7.3–7.4, with osmolarity of 300–310 mOsm)
until the recordings were performed.
Recordings: whole-cell recordings from BLA principal neurons
were performed at 30–32°C in a superfusing chamber as described
previously (28). Neurons were identiﬁed visually by infrared vi-
deomicroscopy using an upright microscope equipped with a
60× objective. Patch electrodes (3–5 MΩ) were pulled from boro-
silicate glass tubing andﬁlledwitha low-chloride solution contain-
ing 140 m Cs-methylsulfonate, 5 m QX314-Cl, 10 m HEPES,
10 mphosphocreatine, 4 mMg-ATPand0.3mNa-GTP (pHad-
justed to 7.25 with CsOH, 295 mOsm). Hippocampo-BLA mono-
synaptic EPSCs were elicited by 1 ms light stimulations delivered
by an ultra-high power 460 nm LED (Prizmatix Ltd, Israel) at max-
imal intensity or increasing intensity when indicated.
Immunohistochemistry
Drosophila NMJ: the following primary antibodies were used:
anti-DLG (1:200, mouse, DSHB), anti-HRP (1:500, rabbit, Jackson
Immuno Research), anti-BRP (nc82, 1:125, mouse, DSHB) and
anti-Syt (syn/DSYT2, 1:100, rabbit, H. Bellen). Type 1b NMJs of
muscle 4 were analysed after dissection of wandering L3 larvae
and ﬁxation in 3.7% PFA for 30 min. Preparations were rinsed
with PBS, blocked and permeabilized with 0.3% Triton X-100 in
PBS (PBST) supplemented with 5% normal goat serum (NGS) for
2 h at room temperature. Primary antibodies were diluted in
PBSTwith 1%NGSand incubatedwith the preparations overnight
at 4°C. Alexa Fluor 488 and 568 secondary antibodies (1:1000;
Invitrogen Molecular Probes) were incubated with the prepara-
tions for 2 h at room temperature. Then, the preparations were
extensively washed and mounted in Vectashield (Vector Labs).
Co-labelling with anti-DLG and anti-BRP, both monoclonal anti-
bodies, was performed by direct conjugation of the primary anti-
body to Alexa 568 using a Zenon Kit (Life Technologies) according
to themanufacturer’s instructions. Fluorescence imageswere ac-
quired using a ZEISS bright-ﬁeld multi-colour epiﬂuorescence
microscope. At least 10 synaptic terminals were analysed per
genotype and quantiﬁed in ImageJ.
Drosophila brains: adult brains were dissected in HL3 dissec-
tion buffer on ice and immediately ﬁxed in cold 4% PFA for
20 min at room temperature. Samples were then rinsed with PBS
containing 1% Tween (PBSTween) and blocked and permeabilized
in 0.3% PBSTween with 10% NGS for 2 h at room temperature. For
primary antibody treatment, samples were incubated in 0.3%
PBTween5% NGS and the anti-Ref(2)p (1:5000, rabbit, G. Juhasz)
for 48 h at room temperature. Secondary antibody Cy3 (1:400, Invi-
trogenMolecular Probes) was incubated for 24 h at room tempera-
ture in 0.3% PBTween with 5% NGS. Brains were then mounted in
Vectashield® (Vector Labs) for 24 h at −20°C before confocal scan-
ning. Image stacks of specimenswere imaged on a Leica TCS SP8X
confocalmicroscope (LeicaMicrosystems) using a 20× glycerol ob-
jective for whole brain imaging. Images were quantiﬁed using Fiji
software (Fiji.sc/Fiji). Brieﬂy, confocal stacks were merged into a
single plane by using the maximum projection function. Subse-
quently, region of central brain was manually selected (using the
free hand tool) and ﬂuorescence intensity (arbitrary units) was
measured and normalized to the area of the central brain for
each brain. Non-parametric test and means comparison were
made using Mann–Whitney test.
Mouse: after the behavioural pipeline, 34-week-old
Atp6ap2Camk2aCre/0 and wt males (four of each genotype) were
deeply anesthetised with pentobarbital and perfused intracar-
dially with 30 ml of PBS, followed by perfusion with 30 ml of 4%
PFA in PBS. The brainsweredissected, postﬁxed for at least 48 h in
4% formalin solution andwashed in 70% ethanol. After the brains
were embedded in parafﬁn, they were cut into 5-µm thick frontal
sections. Immunohistochemistry was performed using a stand-
ard protocol. Brieﬂy, antigen retrieval was performed by heating
the slides in citric acid buffer (10 m citric acid, 0.05% Tween 20,
pH 6.0) or Tris/EDTA buffer (10 m Tris Base, 1 m EDTA, 0.05%
Tween 20, pH 9.0) for 45 min in a 94°C water bath. Then, the sec-
tionswere blockedwith 10%normal horse serum and 0.3% Triton
X-100 in 1× PBS for 1 h at room temperature. The sectionswere in-
cubated overnight at 4°C with the appropriate primary antibody
(see Supplementary Material, Table S1). The primary antibodies
were detected by incubating the sections with Alexa Fluor 488-
or 555-conjugated secondary antibody (1:500; Invitrogen Molecu-
lar Probes) for 1 h at room temperature. Then, the sections were
mountedwithMowiolmountingmedium [0.1 Tris (pH 8.5), 25%
glycerol, 10% w/v Mowiol 4–88 (Citiﬂuor)] containing DAPI (5 μg/
ml), and imageswere acquired using a HamamatsuNanoZoomer
2.0 (Hamamatsu, Hamamatsu City, Japan) and a Leica DMRXA2
epiﬂuorescence microscope (Leica Microsystems, Heidelberg,
Germany).
Electron microscopy
Drosophila eye: UAS-ATP6AP2RNAi1, UAS-ATP6AP2RNAi2 and UAS-
Vha100-1RNAi with their corresponding genetic background
control lines were crossed with GMR-Gal4 virgins and raised at
25°C. Dissected heads from 3- to 4-day-old females were preﬁxed
in 2% glutaraldehyde (GA) buffered with 0.1  sodium cacodylate
(pH 7.4). After the heads were incubated for 30 min, they were
taken out, dissected and then put back into the ﬁxative for 24 h.
Subsequently, the dissected heads were postﬁxed for 1 h in 1%
osmium tetroxide in Palade buffer (pH 7.4) with 1% kaliumhexa-
cyanoferrat(III)-trihydrat, dehydrated in ethanol and propylene
oxide and embedded in a single drop of Epon. Semi-thin (1 µm
thick) transverse and longitudinal sections were stained with
1% toluidine blue. Ultrathin sections were stained with uranyl
acetate and lead citrate and then examined using a JEOL 1200
electron microscope.
Drosophila NMJ: UAS-ATP6AP2RNAi1 and its corresponding
genetic background control line were crossed with UAS-Dicer-2;
elav-Gal4 virgins and raised at 28°C. Open book preparations of
third instar larvae were ﬁxed in 4% PFA and 0.5% GA for 10 min,
followed by 1 h ﬁxation in 2% GA in 0.1  sodium cacodylate buf-
fer at room temperature. The larvae were postﬁxed on ice in the
dark with 1% OsO4 in 0.8% KFeCN, washed with NaCac buffer for
1 h and stained with 1% uranyl acetate (UAc). Subsequently, the
preparations were dehydrated in ethanol and propylene oxide
and embedded in a single drop of Epon. Muscle 4 of abdominal
segments 2 to 5 was dissected, and multiple muscles were
stacked and embedded in an Epon block, which was heated over-
night at 60°C for polymerization. Ultrathin sections (50–70 nm)
were prepared using a Reichert Ultracut E ultramicrotome (Leica),
mounted on copper electron microscopy grids and counter
stained using UAc and lead citrate. The sections were examined
at varying nominal magniﬁcations using a 100 kV Philips CM100
microscope equipped with a F114 Fastscan CCD camera (TVIPS)
or using a 120 kV Tecnai Spirit microscope equipped with a 2 k
Eagle CCD camera (FEI).
Mice: 12- to 14-week-old mice (three of each genotype) were
deeply anesthetised with pentobarbital and perfused intracar-
dially with 30 ml of PBS, followed by perfusion with 30 ml of 4%
PFA in PBS. The brain was dissected and put in 4% PFA solution
in PBS at 4°C. Then, one portion of the cortex and hippocampus
was processed for morphological analysis by immersion in 2.5%
glutaraldehyde and 2.5% paraformaldehyde in cacodylate buffer
(0.1 , pH 7.4), postﬁxed in 1% osmium tetroxide in 0.1  cacody-
late buffer for 1 h at 4°C and dehydrated through graded ethanol
(50, 70, 90 and 100%) and propylene oxide for 30 min each. The
samples were embedded in Epon 812. Semi-thin sections were
cut at 2 µmwith an ultramicrotome (Leica Ultracut UCT), stained
with toluidine blue and analysed histologically by light micros-
copy. Ultrathin sections were cut at 70 nm, contrast strained
with uranyl acetate and lead citrate and examined at 70 kv
using a Morgagni 268D electron microscope. Images were cap-
tured digitally using a Mega View III camera (Soft Imaging Sys-
tem). The other portion of the cortex and hippocampus was
processed for immunogold experiment by ﬁxation for 1 h in 2%
PFA—0.2% glutaraldehyde solution in PBS. Then, the brains
were blocked in a solution of 0.1% NaBH4 in PBS and in a second
solution composed of 5% BSA, 0.1% CWFSkin gelatin and 1% NGS
(Aurion). Next, the brains were incubated at room temperature
for 1 h with ATP6ap2 antibody (see Supplementary Material,
Table S1), whichwas diluted in 1%NGS in PBS and then incubated
with secondary goat anti-rabbit antibody, which was coupled to
gold ultra-small particles (Aurion) and diluted in 1% NGS in
PBS, for 2 h 30 min at room temperature. After the brains were
washed, they were ﬁxed in 2% glutaraldehyde solution in PBS.
Silver enhancement of gold ultra-small particles was performed
using R-Gent SE-EM (Aurion). Then, the samples were processed
as described earlier starting from post-ﬁxation in 1% osmium
tetroxide in 0.1  cacodylate buffer.
RNA sequencing
Total RNA was extracted from two wild-type and two mutant
samples (frozen hippocampus) using TRIzol. Then total RNA
was treated with DNase (Qiagen, 79254) and puriﬁed using an
RNeasy MinElute Cleanup Kit (Qiagen, 74204). In total, 2000 ng
of total RNA was treated with a Ribo-Zero rRNA Removal Kit
(human/mouse/rat; Illumina MRZH11124). The depleted RNA
was precipitated for 1 h at −80°C in three volumes of ethanol
plus 1 µg of glycogen. Then, the RNA was washed and resus-
pended in 36 µl of RNase-free water. RNA fragmentation buffer
(NEBNext® Magnesium RNA Fragmentation Module, E6150S)
was added to the solution, and the RNAwas fragmented by incu-
bation at 95°C for 3 min. For reverse transcription, cDNA ﬁrst-
strand synthesis was performed with random hexamer primers.
cDNA second-strand synthesis was performedwith dNTPs to en-
sure strand speciﬁcity. The RNA-seq library was synthesized
using a KAPA Hyper prep kit (KK8504), and a treatment with
USER enzyme (NEB, M5505L) was added to digest the non-speciﬁc
strand. The libraries were pooled (4/lane), sequenced on an Illu-
mina HiSeq and yielded ∼40million single-end reads per sample.
The complete data set and the processed data were submitted to
Geo (GSE 67541). The RNA-seq libraries were mapped using
GSNAP, the gene expression counts were calculated with a cus-
tom C++ script and DEseq2 was used to call the dysregulated
genes. TheGOenrichmentswere calculated in theDAVIDwebsite
(http://david.abcc.ncifcrf.gov/) and in the Bingo tools for Cytos-
cape (http://apps.cytoscape.org/apps/bingo) and by performing
a standard hypergeometric test on theMus musculus GO annota-
tions (updated to version 22/02/2015). The results of all the en-
richments can be found in the Supplementary Material.
Statistical analysis
The data were analysed using unpaired Student’s t-test or re-
peated-measures analysis of variance (ANOVA) with one be-
tween factors (genotype) and one within factor (time, quadrant)
unless stated otherwise. Qualitative parameters (e.g. clinical ob-
servations) were analysed using the χ2 test. The level of signiﬁ-
cance was set at P < 0.05.
Supplementary Material
Supplementary Material is available at HMG online.
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